**Background** Chemotherapy resistance is one of the major reasons for treatment failure and tumour recurrence in colorectal cancer. Recent studies indicate that cancer stem cells …
Cancer is a heterogeneous disease and consists of multiple molecular subtypes underlying the diverse clinical outcomes. Most strategies for cancer molecular subtyping are mainly …
**Background**: Cancers of the gastrointestinal (GI) system, including esophagus, stomach, pancreas, gallbladder, liver, bile duct, colon, and rectum are estimated to account for …
3613 **Background**: Colorectal cancer is one of the most common malignancies with a high mortality rate. Patients with stage I and stage II colorectal cancer have limited options …
**Background**: Immune-related genes (IRGs) were found to be associated with the prognosis of colorectal cancer (CRC) patients. The aim of this study was to evaluate the impact of …
Purpose Among more than 100 known post-transcriptional modifications, N6-Methyladenosine (m6A) represents the most prevalent internal modification in mammalian mRNAs. This …
High-throughput screens (HTS) is one of the most promising tools in functional genomics and enables scientists to study genome-wide perturbations. Our previous work, HTSanalyzeR, …